I created a Telegram channel dedicated to AbCellera ($ABCL)
I’ve been following AbCellera ($ABCL) closely for a while, and I realized there isn’t really one place where all the relevant information about the company is collected.
News and discussion are scattered across Reddit, X, SEC filings, [ClinicalTrials.gov](http://ClinicalTrials.gov), scientific publications, conference presentations and company releases.
So I created a free Telegram channel dedicated specifically to AbCellera:
u/abcelleranews
The goal is to collect and share anything that could actually matter to the ABCL investment thesis:
* Company and pipeline news
* Clinical trial updates
* ABCL635 and ABCL575 developments
* New partnerships and milestones
* SEC filings
* Scientific publications
* Conference updates
* Institutional activity
* Relevant research and analysis
* Interesting discussions from Reddit and X
I’m an ABCL shareholder myself, but I don’t want this to become a bullish echo chamber.
Positive developments are worth discussing, but so are trial setbacks, partnership failures, pipeline changes or anything else that could weaken the thesis.
No pumps, no price targets every five minutes, no spam. Just trying to keep the signal-to-noise ratio as high as possible.
The channel is completely free, independent and not affiliated with AbCellera.
If you follow ABCL or are researching the company, feel free to join:
Telegram: u/abcelleranews
And if you find relevant ABCL research or news that I’ve missed, send it over. I’d like this to become a useful resource for people seriously following the company.